“A standardized preadmission shower regimen that includes 118 mL (full 4 oz bottle) of aqueous chlorhexidine gluconate, 4%, per shower; a minimum of 2 sequential showers; and a 1-minute pause before rinsing results in maximal skin surface (16.5 µg/cm) concentrations of chlorhexidine gluconate that are sufficient to inhibit or kill gram-positive or gram-negative surgical wound pathogens. This showering regimen corrects deficiencies present in current non standardized preadmission shower protocols for patients undergoing elective surgery.” Edmiston, et al. JAMA Aug 2015
Pre-op Showers with Chlorhexidine Washcloths
http://www.sageproducts.com/
The First FDA-Approved Preoperative Skin Prep in a Cloth
Sage 2% CHG Cloths address multidrug resistant organisms (MDROs) on the
patients' skin - a known risk factor for SSIs.1 Sage's innovative rinse-free, alcohol-free formula is designed for early preop prep. It stays on the skin for maximum persistence. The cloth consistently delivers a uniform dose of CHG, unlike other soaps and solutions.
2% FORMULA PROVEN EFFECTIVE
Effective against broad spectrum of MDROs, including MRSA, VRE
and Acinetobacter. Recognized by CDC as having "excellent" activity against gram-positive bacteria as well as "excellent" residual activity
Sage 2% CHG Cloths address multidrug resistant organisms (MDROs) on the
patients' skin - a known risk factor for SSIs.1 Sage's innovative rinse-free, alcohol-free formula is designed for early preop prep. It stays on the skin for maximum persistence. The cloth consistently delivers a uniform dose of CHG, unlike other soaps and solutions.
2% FORMULA PROVEN EFFECTIVE
Effective against broad spectrum of MDROs, including MRSA, VRE
and Acinetobacter. Recognized by CDC as having "excellent" activity against gram-positive bacteria as well as "excellent" residual activity
Hibiclens Chlorhexidine Antiseptic Skin Cleanser
http://www.hibigeebies.com/
Hibiclens® the antimicrobial antiseptic skin cleanser can be an effective defense for preventing the spread of MRSA and other staph infections in your facilities. Its active ingredient, CHG works in a unique way- it kills germs on contact and bonds with the skin to keep killing microorganisms even after washing.
HIBICLENS is bactericidal on contact. It has antiseptic activity and a
persistent antimicrobial effect with rapid bactericidal activity against a wide
range of microorganisms, including gram-positive bacteria and gram-negative
bacteria such as Pseudomonas aeruginosa. The effectiveness of HIBICLENS is not
significantly reduced by the presence of organic matter, such as blood. In a study simulating surgical use, the immediate bactericidal effect of HIBICLENS after a single six-minute scrub resulted in a 99.9% reduction in resident bacterial flora, with a reduction of 99.98% after the eleventh scrub. Reductions on surgically gloved hands were maintained over the six-hour test period. HIBICLENS displays persistent antimicrobial action. In one study, 93% of a radiolabeled formulation of HIBICLENS remained present on uncovered skin after five hours. HIBICLENS helps prevent skin infection thereby
reducing the risk of cross-infection.
HIBICLENS is bactericidal on contact. It has antiseptic activity and a
persistent antimicrobial effect with rapid bactericidal activity against a wide
range of microorganisms, including gram-positive bacteria and gram-negative
bacteria such as Pseudomonas aeruginosa. The effectiveness of HIBICLENS is not
significantly reduced by the presence of organic matter, such as blood. In a study simulating surgical use, the immediate bactericidal effect of HIBICLENS after a single six-minute scrub resulted in a 99.9% reduction in resident bacterial flora, with a reduction of 99.98% after the eleventh scrub. Reductions on surgically gloved hands were maintained over the six-hour test period. HIBICLENS displays persistent antimicrobial action. In one study, 93% of a radiolabeled formulation of HIBICLENS remained present on uncovered skin after five hours. HIBICLENS helps prevent skin infection thereby
reducing the risk of cross-infection.
The StartClean Cleansing Program
www.bd.com/en-us/videos/startclean-patient-cleansing-instructional-video
www.bd.com/en-us/videos/startclean-patient-cleansing-instructional-video
| ip_startclean-patient-ed-template_pe.pdf |
| Edmiston et al. Chlorehexidine_Pre-Op_Methodology_JAMA Surgery_2015.pdf |
| Infection Control_Today_CHG_Bathing_report.pdf |
| Edmiston_et_al_JACS_2014_Empowerng_the_Surgical_Patient_for_Preop_Shower.pdf |
| Lipke_and_Hyott_-_Reducing_SSIs_by_Bundling_Multiple_rRsk_Reduction_Strategies_and_Active_Surveillance_-_AORN_2010.pdf |
| APIC_Symposium_-_CHG_Irrigation_Bathing_and_Skin_Antisepsis_June_6_2012_3.pdf |
| Edmiston, et l JACS_2008_CHG_Washcloths.pdf |
| IHI_Project_Joints_-_CHG_Bathing.ppt |
| Clinical_References_for_CHG_Washcloths.doc |
| Johnson-Mont_JOA_April_2010_CHG_Washcloths.pdf |
| Poster_on_C_Section_Reduction_with_CHG_Cloths.pdf |
| Lipke_C Section.pdf |
| CHG_C Section.pdf |
| Hendrickson_C Section.pdf |
| Start Clean Education Template_en.pdf |
